Oxford BioMedica (LON:OXB) Stock Passes Below Two Hundred Day Moving Average of $0.00

Share on StockTwits

Oxford BioMedica plc (LON:OXB) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.00 and traded as low as $679.00. Oxford BioMedica shares last traded at $690.00, with a volume of 18,687 shares trading hands.

Separately, Peel Hunt reiterated a “buy” rating and issued a GBX 60 ($0.78) price objective on shares of Renewi in a research note on Wednesday, July 3rd.

The company has a current ratio of 2.44, a quick ratio of 2.26 and a debt-to-equity ratio of 118.46. The firm has a market cap of $529.70 million and a P/E ratio of 63.30. The business has a 50-day moving average price of GBX 722.60.

In other Oxford BioMedica news, insider Lorenzo Tallarigo bought 370 shares of the business’s stock in a transaction on Wednesday, June 26th. The stock was bought at an average price of GBX 722 ($9.43) per share, for a total transaction of £2,671.40 ($3,490.66). Also, insider Andrew Heath bought 3,312 shares of the business’s stock in a transaction on Tuesday, April 23rd. The shares were acquired at an average price of GBX 673 ($8.79) per share, with a total value of £22,289.76 ($29,125.52). In the last 90 days, insiders have acquired 4,449 shares of company stock valued at $3,031,022.

About Oxford BioMedica (LON:OXB)

Oxford BioMedica plc, a biopharmaceutical company, engages in the research, development, and bioprocessing of lentiviral vector and cell therapy products for the treatment of various cancers, Parkinson's, central nervous system disorders, and ocular conditions in Europe and internationally. The company operates through Platform and Product segments.

Featured Story: Buy-Side Analysts

Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.